Infant Bacterial Therapeutics AB (IFTBF)
6.85
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Infant Bacterial Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2017 | -11.47K% |
| Date | Value |
|---|---|
| March 31, 2017 | -7.33K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orexo AB | -2.93K% |
| Swedencare AB | 3.54% |
| Camurus AB | 34.30% |
| Moberg Pharma AB | -56.91% |
| AstraZeneca PLC | 20.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -83.01% |
| Return on Assets | -52.14% |
| Return on Invested Capital | -83.01% |
| Return on Net Operating Assets | -889.6% |